Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study.

Ther Adv Musculoskelet Dis · 2022 · PMC9109492 · PMID 35586513

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The drug discontinuation rate due to adverse events was higher in the MMF group than in the MZR group, but the differences observed did not reach statistical significance [ Figure 4(c) ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.